Αρχική World News ESMO Virtual Congress 2020, 19-21 September

ESMO Virtual Congress 2020, 19-21 September [ESMO Media Alert]

LUGANO, Switzerland – The ESMO Congress 2020 will be held as a virtual meeting, with the programme delivered over two weekends:

  • Science weekend on 19-21 September
  • Educational weekend on 16-18 October

ESMO welcomes media interested in reporting from the ESMO meetings and on cancer issues. Only through the official accreditation process with the ESMO Media Registration Form accredited media representatives will be able to access embargoed material and official press conferences.

The scientific programme will include the presentation of the latest cancer research results with more than 2100 abstracts, including around 100 expected late-breaking abstracts. Abstract titles are already listed in the online programme, the titles of accepted late-breaking abstracts will be made available at the end of August.

Please note the new embargo schedule for the ESMO Virtual Congress 2020:

  1. Abstracts accepted for presentation at the ESMO Virtual Congress 2020 as Poster (suffix ‘P’, ‘TiP’) and EONS Poster (prefix ‘CN’) will be published online via the ESMO website at 00:05 CEST on Monday, 14 September 2020.
  2. Abstracts and late-breaking abstracts accepted for presentation at the ESMO Virtual Congress 2020 as Mini Oral (suffix ‘MO’) will be published online via the ESMO website at 00:05 CEST on Friday, 18 September 2020.
  3. Abstracts and late-breaking abstracts accepted for presentation at the ESMO Virtual Congress 2020 as Proffered Paper (suffix ‘O’) and EONS Proffered Paper (prefix ‘CN’) will be published online via the ESMO website at 00:05 CEST on Saturday, 19 September 2020.
  4. Abstracts and late-breaking abstracts selected for inclusion in the ESMO Press Programme will be published online according to a dedicated schedule which will be made available by early September.
  • Data and information included in accepted abstracts is under embargo until the relevant embargo release date cited in the schedule above.
  • Data and information beyond what is included in all accepted abstracts, including full data sets and full manuscripts, may only be made public at the start of the official programme session during which the study is presented.

Media representatives are required to observe and abide by the ESMO Media Policy which applies to all ESMO meetings.

Further information

ESMO Press Office




Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women Under 40

U.S. breast cancer death rates decreased by about 1% per year between 2013 and 2018. What were the new case rates during that same...

Impressive Responses to PD-1 Blockade in a Large Cohort of Children and Young Adults with Recurrent/Progressive Germline DNA Replication Repair-Deficient Cancers

A large, observational, registry-based study that leveraged systematically collected data gathered both retrospectively and prospectively through the International Replication Repair Deficiency Consortium reveals impressive...

2-Year-Boy Is So Excited To See Himself In Disney’s ‘Encanto’

The importance of representation in media has been a growing topic of concern, and companies have responded by adding more diversity to their characters,...

Man Walks Entire Continent To Spread Awareness About Mental Health & Suicide Prevention

Matthew Fennell is walking over 3,000 miles across Australia for an important cause and one that is near and dear to his heart. Last year,...

Boy Battling Cancer Becomes Honorary Police Officer, Sworn In To 45 Agencies

At just ten years old, Devarjaye “DJ” Daniel has already been through more than most people go through in their entire lives. DJ has been...

Paclitaxel and Carboplatin Not Inferior When Compared with Paclitaxel and Ifosfamide for the Treatment of Patients with Uterine Carcinosarcoma

With regard to overall survival (OS), paclitaxel and carboplatin was not inferior and demonstrated improved progression-free survival (PFS) when compared with paclitaxel and ifosfamide...